highly significantp < 0.001
Treatment‐time interaction highly significant ( p < 0.001) (Figure 6 ). 3.3.4 Pain VAS scores decreased from 7.5 ± 1.2 to 2.5 ± 1.2 (Δ‐5.0) in HBO versus 7.3 ± 1.3 to 5.8 ± 1.4 (Δ‐1.5) in control, with significant treatment‐time interaction ( p < 0.001) (Figure 7 ). 3.3.5 Quality of Life Wound‐QoL scores improved from 58.3 ± 12.1 to 35.6 ± 10.3 at day 30 in HBO versus 57.8 ± 11.9 to 45.7 ± 11.5 in control ( p < 0.001).